[(11)C, (127)I] Altropane: a highly selective ligand for PET imaging of dopamine transporter sites (Q31911300)

From Wikidata

Jump to navigation Jump to search

scientific article

[11C,127I] Altropane: A highly selective ligand for PET imaging of dopamine transporter sites

Language	Label	Description	Also known as
English	[(11)C, (127)I] Altropane: a highly selective ligand for PET imaging of dopamine transporter sites	scientific article	[11C,127I] Altropane: A highly selective ligand for PET imaging of dopamine transporter sites

Statements

scholarly article

1 reference

Europe PubMed Central

5 July 2017

[(11)C, (127)I] Altropane: a highly selective ligand for PET imaging of dopamine transporter sites (English)

1 reference

Europe PubMed Central

5 July 2017

author name string

Fischman AJ

1

1 reference

Europe PubMed Central

5 July 2017

Bonab AA

2

1 reference

Europe PubMed Central

5 July 2017

Babich JW

3

1 reference

Europe PubMed Central

5 July 2017

Livni E

4

1 reference

Europe PubMed Central

5 July 2017

Alpert NM

5

1 reference

Europe PubMed Central

5 July 2017

Meltzer PC

6

1 reference

Europe PubMed Central

5 July 2017

Madras BK

7

1 reference

Europe PubMed Central

5 July 2017

publication date

1 March 2001

1 reference

Europe PubMed Central

5 July 2017

1 reference

Europe PubMed Central

5 July 2017

39

1 reference

Europe PubMed Central

5 July 2017

4

1 reference

Europe PubMed Central

5 July 2017

332-342

1 reference

Europe PubMed Central

5 July 2017

Lipophilic metabolite of [123I]beta-CIT in human plasma may obstruct quantitation of the dopamine transporter.

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C332%3A%3AAID-SYN1017%3E3.0.CO%3B2-X

21 January 2018

[125I]RTI-55: a potent ligand for dopamine transporters

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C332%3A%3AAID-SYN1017%3E3.0.CO%3B2-X

21 January 2018

[123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C332%3A%3AAID-SYN1017%3E3.0.CO%3B2-X

21 January 2018

Practical benefit of [123I]FP-CIT SPET in the demonstration of the dopaminergic deficit in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C332%3A%3AAID-SYN1017%3E3.0.CO%3B2-X

21 January 2018

Autoradiographic localization of cocaine binding sites by [3H]CFT ([3H]WIN 35,428) in the monkey brain.

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C332%3A%3AAID-SYN1017%3E3.0.CO%3B2-X

21 January 2018

Dopamine transporter density in patients with attention deficit hyperactivity disorder.

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C332%3A%3AAID-SYN1017%3E3.0.CO%3B2-X

21 January 2018

PET study of [11C]beta-CIT binding to monoamine transporters in the monkey and human brain.

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C332%3A%3AAID-SYN1017%3E3.0.CO%3B2-X

21 January 2018

Rapid detection of Parkinson's disease by SPECT with altropane: a selective ligand for dopamine transporters

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C332%3A%3AAID-SYN1017%3E3.0.CO%3B2-X

21 January 2018

Positron emission tomographic imaging of the dopamine transporter with 11C-WIN 35,428 reveals marked declines in mild Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C332%3A%3AAID-SYN1017%3E3.0.CO%3B2-X

21 January 2018

[11C]RTI-32 PET studies of the dopamine transporter in early dopa-naive Parkinson's disease: implications for the symptomatic threshold.

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C332%3A%3AAID-SYN1017%3E3.0.CO%3B2-X

21 January 2018

[11C]beta-CIT-FE, a radioligand for quantitation of the dopamine transporter in the living brain using positron emission tomography.

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C332%3A%3AAID-SYN1017%3E3.0.CO%3B2-X

21 January 2018

Single photon emission computed tomography imaging of monoamine reuptake sites in primate brain with [123I]CIT

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C332%3A%3AAID-SYN1017%3E3.0.CO%3B2-X

21 January 2018

Severe depletion of cocaine recognition sites associated with the dopamine transporter in Parkinson's-diseased striatum

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C332%3A%3AAID-SYN1017%3E3.0.CO%3B2-X

21 January 2018

Distribution of cocaine recognition sites in monkey brain: II. Ex vivo autoradiography with [3H]CFT and [125I]RTI-55

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C332%3A%3AAID-SYN1017%3E3.0.CO%3B2-X

21 January 2018

[3H]CFT ([3H]WIN 35,428) accumulation in dopamine regions of monkey brain: comparison of a mature and an aged monkey.

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C332%3A%3AAID-SYN1017%3E3.0.CO%3B2-X

21 January 2018

Iodine-123 labelled N-(2-fluoroethyl)-2 beta-carbomethoxy-3 beta-(4-iodophenyl)nortropane for dopamine transporter imaging in the living human brain.

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C332%3A%3AAID-SYN1017%3E3.0.CO%3B2-X

21 January 2018

Comparison of iodine-123 labelled 2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane and 2 beta-carbomethoxy-3 beta-(4-iodophenyl)-N-(3-fluoropropyl)nortropane for imaging of the dopamine transporter in the living human brain.

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C332%3A%3AAID-SYN1017%3E3.0.CO%3B2-X

21 January 2018

SPECT imaging of dopamine and serotonin transporters with [123I]beta-CIT: pharmacological characterization of brain uptake in nonhuman primates.

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C332%3A%3AAID-SYN1017%3E3.0.CO%3B2-X

21 January 2018

Graphical, kinetic, and equilibrium analyses of in vivo [123I] beta-CIT binding to dopamine transporters in healthy human subjects.

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C332%3A%3AAID-SYN1017%3E3.0.CO%3B2-X

21 January 2018

Unilateral MPTP lesion in a rhesus monkey: effects on the striatal dopaminergic system measured in vivo with PET using various novel tracers.

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C332%3A%3AAID-SYN1017%3E3.0.CO%3B2-X

21 January 2018

The nigrostriatal dopaminergic system assessed in vivo by positron emission tomography in healthy volunteer subjects and patients with Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C332%3A%3AAID-SYN1017%3E3.0.CO%3B2-X

21 January 2018

Cocaine accumulates in dopamine-rich regions of primate brain after i.v. administration: comparison with mazindol distribution.

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C332%3A%3AAID-SYN1017%3E3.0.CO%3B2-X

21 January 2018

Altropane, a SPECT or PET imaging probe for dopamine neurons: II. Distribution to dopamine-rich regions of primate brain

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C332%3A%3AAID-SYN1017%3E3.0.CO%3B2-X

21 January 2018

Altropane, a SPECT or PET imaging probe for dopamine neurons: III. Human dopamine transporter in postmortem normal and Parkinson's diseased brain

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C332%3A%3AAID-SYN1017%3E3.0.CO%3B2-X

21 January 2018

[123I] beta-CIT/SPECT imaging demonstrates bilateral loss of dopamine transporters in hemi-Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C332%3A%3AAID-SYN1017%3E3.0.CO%3B2-X

21 January 2018

A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C332%3A%3AAID-SYN1017%3E3.0.CO%3B2-X

21 January 2018

Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with [18F]dopa PET.

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C332%3A%3AAID-SYN1017%3E3.0.CO%3B2-X

21 January 2018

[11C] beta-CIT, a cocaine analogue. Preparation, autoradiography and preliminary PET investigations.

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C332%3A%3AAID-SYN1017%3E3.0.CO%3B2-X

21 January 2018

[123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane: high-affinity SPECT radiotracer of monoamine reuptake sites in brain.

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C332%3A%3AAID-SYN1017%3E3.0.CO%3B2-X

21 January 2018

N-omega-fluoroalkyl analogs of (1R)-2 beta-carbomethoxy-3 beta-(4-iodophenyl)-tropane (beta-CIT): radiotracers for positron emission tomography and single photon emission computed tomography imaging of dopamine transporters.

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C332%3A%3AAID-SYN1017%3E3.0.CO%3B2-X

21 January 2018

Cocaine receptors on dopamine transporters are related to self-administration of cocaine

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C332%3A%3AAID-SYN1017%3E3.0.CO%3B2-X

21 January 2018

Decreased single-photon emission computed tomographic [123I]beta-CIT striatal uptake correlates with symptom severity in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C332%3A%3AAID-SYN1017%3E3.0.CO%3B2-X

21 January 2018

In vivo imaging of dopamine reuptake sites in the primate brain using single photon emission computed tomography (SPECT) and iodine-123 labeled RTI-55

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C332%3A%3AAID-SYN1017%3E3.0.CO%3B2-X

21 January 2018

Drug-naive patients with Parkinson's disease in Hoehn and Yahr stages I and II show a bilateral decrease in striatal dopamine transporters as revealed by [123I]beta-CIT SPECT.

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C332%3A%3AAID-SYN1017%3E3.0.CO%3B2-X

21 January 2018

Relationship between subjective effects of cocaine and dopamine transporter occupancy.

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C332%3A%3AAID-SYN1017%3E3.0.CO%3B2-X

21 January 2018

In vivo imaging of baboon and human dopamine transporters by positron emission tomography using [11C]WIN 35,428.

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C332%3A%3AAID-SYN1017%3E3.0.CO%3B2-X

21 January 2018

Dopamine transporters are markedly reduced in Lesch-Nyhan disease in vivo

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C332%3A%3AAID-SYN1017%3E3.0.CO%3B2-X

21 January 2018

A Two-Compartment Description and Kinetic Procedure for Measuring Regional Cerebral [11C]Nomifensine Uptake Using Positron Emission Tomography

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C332%3A%3AAID-SYN1017%3E3.0.CO%3B2-X

21 January 2018

Regional brain uptake and pharmacokinetics of [123I]N-omega-fluoroalkyl-2 beta-carboxy-3 beta-(4-iodophenyl)nortropane esters in baboons

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C332%3A%3AAID-SYN1017%3E3.0.CO%3B2-X

21 January 2018

Radiosynthesis of [18F] N-3-fluoropropyl-2-beta-carbomethoxy-3-beta (4' methylphenyl) nortropane (FPCMT)

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C332%3A%3AAID-SYN1017%3E3.0.CO%3B2-X

21 January 2018

Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: effects of methylphenidate as measured by single photon emission computed tomography

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C332%3A%3AAID-SYN1017%3E3.0.CO%3B2-X

21 January 2018

[O-methyl-11C]beta-CIT-FP, a potential radioligand for quantitation of the dopamine transporter: preparation, autoradiography, metabolite studies, and positron emission tomography examinations

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C332%3A%3AAID-SYN1017%3E3.0.CO%3B2-X

21 January 2018

Identifiers

10.1002/1098-2396(20010315)39:4<332::AID-SYN1017>3.0.CO;2-X

1 reference

Europe PubMed Central

5 July 2017

release_e24mzodfovhqteoefcoag4xev4

1 reference

https://api.fatcat.wiki/v0/release/e24mzodfovhqteoefcoag4xev4

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

5 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q31911300&oldid=1973276045"